Eli Lilly and CompanyLLYNYSE
Loading
Cash Generation ExpandingExpanding
Percentile Rank100
3Y CAGR+24.9%
5Y CAGR+14.9%
Year-over-Year Change
Operating cash flow minus capital expenditures
3Y CAGR
+24.9%/yr
vs +16.4%/yr prior
5Y CAGR
+14.9%/yr
Recent acceleration
Acceleration
+8.5pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $8.97B | +2065.6% |
| 2024 | $414.30M | +113.1% |
| 2023 | $-3.15B | -168.5% |
| 2022 | $4.60B | -14.6% |
| 2021 | $5.39B | +20.5% |
| 2020 | $4.47B | +28.3% |
| 2019 | $3.48B | +39.0% |
| 2018 | $2.51B | -27.4% |
| 2017 | $3.45B | -8.2% |
| 2016 | $3.76B | - |